JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer (Q39226686)

From Wikidata
Jump to navigation Jump to search
scientific article published on December 2012
edit
Language Label Description Also known as
English
JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer
scientific article published on December 2012

    Statements

    JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer (English)
    Adrian Britschgi
    Rita Andraos
    Heike Brinkhaus
    Ina Klebba
    Vincent Romanet
    Urs Müller
    Masato Murakami
    Thomas Radimerski
    Mohamed Bentires-Alj
    1 December 2012
    796-811

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit